Related references
Note: Only part of the references are listed.The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer
Luis Eduardo Murgel de Castro Santos et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies
Shengming Dai et al.
HUMAN GENETICS (2009)
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Stefanie J. Klug et al.
LANCET ONCOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Assessment of cumulative evidence on genetic associations: interim guidelines
John P.A. Ioannidis et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature
Yong Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer
Anita Koushik et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer
JM Lee et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Breast cancer patients with p53 pro72 homozygous genotype have a poorer survival
J Tommiska et al.
CLINICAL CANCER RESEARCH (2005)
p53 codon 72 polymorphism and its association with bladder cancer
N Soulitzis et al.
CANCER LETTERS (2002)
Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumor
WC Chen et al.
UROLOGICAL RESEARCH (2000)
Share Paper
